InnoStar

益诺思 (InnoStar) offers PK/TK, clinical bioanalysis and translational biomarkers. Services should be matched to the intended study and assay requirements.

Corporate information

Company entity
益诺思 (InnoStar)
Headquarters / principal office
Headquarters city not independently verified; see the country/network tags.
Founded
2010 ↗
Ownership / capital status
Publicly tradedPublicly listed; see issuer disclosures ↗ ↗
Official corporate reference
https://innostarbio.com/ ↗
LinkedIn company page
LinkedIn ↗ ↗

Profile review: 2026-11-05 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.

Discuss this company with the research assistant

Start with public sources and capability boundaries; company claims are not independent certification.

Ask AI ↗

Public evidence snapshot

益诺思 (InnoStar) offers PK/TK, clinical bioanalysis and translational biomarkers. Services should be matched to the intended study and assay requirements.

This profile is a research snapshot, not a company endorsement. Check original sources for current information.

Original sources

Related fields

Continue your research

Explore company filters, side-by-side comparisons, private bookmarks, and member discussions.

Open free member tools ↗
AI assistant ↗